World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
23526
World Ranking
17532
National Ranking
8772

Badrinath R. Konety publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Badrinath R. Konety sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 677 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Badrinath R. Konety D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Badrinath R. Konety sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Badrinath R. Konety is affiliated with the University of Minnesota in the United States. Their research output spans multiple areas within medicine, especially focusing on urology, oncology, and surgery. The scope of their work involves studies on cancer treatments, diagnostics, and clinical outcomes, particularly centered on bladder and prostate cancers.

The scientist has a significant record of publication in several frequent venues, including:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Urologic Oncology Seminars and Original Investigations
  • European Urology
  • European Urology Oncology

The most recent papers encompass key contributions to the fields of bladder cancer and prostate cancer, with titles such as:

  • Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study (2021, The Lancet Oncology)
  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial (2020, The Lancet Oncology)
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening (2023, The Journal of Urology)
  • Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials (2020, Cancer)
  • Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review (2020, European Urology)

Frequent coauthors collaborating with this researcher include:

  • Yair Lotan
  • Siamak Daneshmand
  • Ashish M. Kamat
  • Gary D. Steinberg
  • Christopher Weight

Their main fields of study concentrate on medicine broadly, with a strong emphasis on:

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Oncology
  • Urology
  • Social Psychology

Within these disciplines, the primary topics covered by their research publications include:

  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Urological Disorders and Treatments
  • LGBTQ Health, Identity, and Policy
  • Genital Health and Disease

Best Publications

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

    Sam S. Chang;Stephen A. Boorjian;Roger Chou;Peter E. Clark

  • Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

    Dipen J Parekh;Isildinha M Reis;Erik P Castle;Mark L Gonzalgo

  • Active Surveillance for the Management of Prostate Cancer in a Contemporary Cohort

    Marc A. Dall'Era;Badrinath R. Konety;Janet E. Cowan;Katsuto Shinohara

  • Extent of Pelvic Lymphadenectomy and Its Impact On Outcome in Patients Diagnosed With Bladder Cancer: Analysis of Data From the Surveillance, Epidemiology and End Results Program Data Base

    Badrinath R. Konety;Sue A. Joslyn;Michael A. O’Donnell

  • Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.

    Arjun V Balar;Ashish M Kamat;Girish S Kulkarni;Edward M Uchio

  • Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer.

    Sue A. Joslyn;Badrinath R. Konety

  • Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

    Piyush K. Agarwal;Natalia Sadetsky;Badrinath R. Konety;Martin I. Resnick

  • Recurrence of high-risk bladder cancer: a population-based analysis.

    Karim Chamie;Mark S. Litwin;Jeffrey C. Bassett;Timothy J. Daskivich

  • Complications after radical cystectomy: analysis of population-based data.

    Badrinath R. Konety;Veerasathpurush Allareddy;Harry Herr

  • PSA Screening Among Elderly Men With Limited Life Expectancies

    Louise C. Walter;Daniel Bertenthal;Karla Lindquist;Badrinath R. Konety

  • Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

    Ashish M. Kamat;Thomas W. Flaig;H. Barton Grossman;Badrinath Konety

  • Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy

    John Kurhanewicz;Daniel B. Vigneron;Sarah J. Nelson;Hedvig Hricak

  • Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system

    Robert H. Getzenberg;Benjamin W. Light;Paul E. Lapco;Badrinath R. Konety

  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

    Stephen A. Boorjian;Mehrdad Alemozaffar;Badrinath R. Konety;Neal D. Shore

  • Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway

    Shinji Urakami;Hiroaki Shiina;Hideki Enokida;Toshifumi Kawakami

  • Bladder Cancer-associated Nuclear Matrix Proteins

    Robert H. Getzenberg;Badrinath R. Konety;Theresa A. Oeler;Martha M. Quigley

  • IMPACT OF HOSPITAL AND SURGEON VOLUME ON IN-HOSPITAL MORTALITY FROM RADICAL CYSTECTOMY: DATA FROM THE HEALTH CARE UTILIZATION PROJECT

    Badrinath R. Konety;Vibhu Dhawan;Veerasathpurush Allareddy;Sue A. Joslyn

  • Urine based markers of urological malignancy.

    Badrinath R. Konety;Robert H. Getzenberg

  • PSA screening among elderly men with limited life expectancies. Commentary

    Louise C. Walter;Daniel Bertenthal;Karla Lindquist;Badrinath R. Konety

Frequent Co-Authors

Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Nathan Lawrentschuk
Nathan Lawrentschuk University of Melbourne
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Matthew R. Cooperberg
Matthew R. Cooperberg University of California, San Francisco
Christopher J. Kane
Christopher J. Kane University of California, San Diego
Mark S. Litwin
Mark S. Litwin University of California, Los Angeles
B. R. Simon Rosser
B. R. Simon Rosser University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in alternative or parallel paths to medical careers, online degrees in nursing offer accessible and flexible options. Many institutions now offer phd nursing education online programs, ideal for those aiming to lead in academia, research, or healthcare administration. Such programs are structured for working professionals seeking advanced expertise while balancing other commitments.

Undergraduates and registered nurses looking to boost their credentials may consider cheapest bsn programs. These affordable pathways are designed to fast-track RN careers by offering flexible, online coursework.

Individuals with non-nursing bachelor's degrees can explore direct entry msn programs for non-nursing majors. These programs allow career changers to enter nursing at the graduate level without prior nursing experience, opening doors to advanced practice roles.

If you are concerned about competitive admissions, look into nursing programs with high acceptance rates. These schools offer more accessible entry points into the nursing profession and provide a variety of online degree options.

Best Scientists Citing Badrinath R. Konety

Trending Scientists

Recently Published Articles